In its final survey looking at the period between October and December 2022, the CDC estimated that about 77.5 percent of people had infection-induced antibodies against the SARS-CoV-2 virus.
...To harness this potentially transformative tool in future, policymakers and other stakeholders must heed the evidence — and the lessons — now emerging from its use during the COVID-19 pandemic.
Recent Comments